Brown Advisory’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Brown Advisory’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-212,947	Closed	-$24K	–	1379
2018 Q4	$24K	Buy	212,947 +747	+0.4%	+$490	﹤0.01%	1242
2018 Q3	$361K	Buy	212,200 +1,200	+0.6%	+$2.15K	﹤0.01%	1097
2018 Q2	$367K	Buy	211,000 +20,000	+10%	+$34.6K	﹤0.01%	1048
2018 Q1	$350K	Sell	191,000 -8,500	-4%	-$18K	﹤0.01%	924
2017 Q4	$445K	Buy	199,500 +41,500	+26%	+$103K	﹤0.01%	909
2017 Q3	$458K	Buy	158,000 +79,500	+101%	+$271K	﹤0.01%	875
2017 Q2	$349K	Buy	+78,500	New	+$324K	﹤0.01%	969

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Brown Advisory's SGYP Position: Q1 2019 in Review

Brown Advisory sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 212,947 shares — an estimated $24K sold.

Brown Advisory first reported a position in SGYP in Q2 2017 and held it in 7 quarters. The position peaked at $458K in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Brown Advisory reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Brown Advisory sold 212,947 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $24K.
Brown Advisory first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 7 quarters.
Brown Advisory's Synergy Pharmaceuticals, Inc Common Stock position peaked at $458K in Q3 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Brown Advisory's 13F filing for Q1 2019, filed 15 May 2019.